Have a feature idea you'd love to see implemented?
Let us know!
MD Mednax Inc
Price (delayed)
$14.09
Market cap
$1.21B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.07
Enterprise value
$1.79B
Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of
Highlights
The quick ratio has grown by 18% year-on-year and by 3.8% since the previous quarter
The debt has decreased by 3.3% YoY and by 2.1% from the previous quarter
The equity is down by 24% YoY but it is up by 3.7% QoQ
Mednax's gross profit has increased by 2.4% from the previous quarter but it has decreased by 2.1% YoY
Key stats
What are the main financial stats of MD
Market
Valuations
Earnings
Shares outstanding
85.88M
Market cap
$1.21B
Enterprise value
$1.79B
Price to book (P/B)
1.65
Price to sales (P/S)
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.89
Revenue
$2.01B
Gross profit
$426.99M
Net income
-$253.84M
EBIT
-$232.41M
EBITDA
-$197.99M
Free cash flow
$115.19M
Per share
Balance sheet
Liquidity
EPS
-$3.07
EPS diluted
-$3.06
Free cash flow per share
$1.37
Book value per share
$8.53
Revenue per share
$23.92
TBVPS
$9.83
Total assets
$2.08B
Total liabilities
$1.34B
Debt
$683.65M
Equity
$732.49M
Working capital
$155.14M
Debt to equity
0.93
Current ratio
1.42
Quick ratio
1.36
Net debt/EBITDA
-2.93
Margins
Efficiency
Dividend
EBITDA margin
-9.9%
Gross margin
21.3%
Net margin
-12.6%
Operating margin
-10.4%
Return on assets
-12%
Return on equity
-32.3%
Return on invested capital
-20.8%
Return on capital employed
-13.6%
Return on sales
-11.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MD stock price
How has the Mednax stock price performed over time
Intraday
-1.12%
1 week
0.14%
1 month
-2.76%
1 year
57.25%
YTD
51.51%
QTD
21.57%
Financial performance
How have Mednax's revenue and profit performed over time
Revenue
$2.01B
Gross profit
$426.99M
Operating income
-$208.56M
Net income
-$253.84M
Gross margin
21.3%
Net margin
-12.6%
The operating margin has declined by 3% since the previous quarter
MD's operating income is down by 3.2% since the previous quarter
The gross margin has grown by 2.4% since the previous quarter
Mednax's gross profit has increased by 2.4% from the previous quarter but it has decreased by 2.1% YoY
Growth
What is Mednax's growth rate over time
Valuation
What is Mednax stock price valuation
P/E
N/A
P/B
1.65
P/S
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.89
The P/B is 65% above the last 4 quarters average of 1.0 but 8% below the 5-year quarterly average of 1.8
The equity is down by 24% YoY but it is up by 3.7% QoQ
The stock's price to sales (P/S) is 48% more than its last 4 quarters average of 0.4 but 26% less than its 5-year quarterly average of 0.8
Efficiency
How efficient is Mednax business performance
MD's return on equity is down by 8% since the previous quarter
The ROIC is down by 4.5% from the previous quarter
The company's return on sales fell by 2.7% QoQ
The ROA has contracted by 3.4% from the previous quarter
Dividends
What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MD.
Financial health
How did Mednax financials performed over time
The total assets is 54% greater than the total liabilities
The quick ratio has grown by 18% year-on-year and by 3.8% since the previous quarter
The company's current ratio rose by 18% YoY and by 2.9% QoQ
The debt is 7% less than the equity
MD's debt to equity is up by 27% year-on-year but it is down by 6% since the previous quarter
The equity is down by 24% YoY but it is up by 3.7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.